Start your
treatment off
right with
VENCLEXTA
Actor portrayal.
Getting started
VENCLEXTA is an oral medicine taken by mouth each day. VENCLEXTA is taken in combination with azacitidine, or decitabine, or low-dose cytarabine. Your healthcare provider can advise which VENCLEXTA combination regimen may be appropriate for you.
You will start taking VENCLEXTA at a low dose and gradually increase to a higher dose—this is called a “ramp-up period.” The ramp-up dosing will depend on which regimen you and your healthcare provider have chosen. Once you’re at the full dose, continue to take VENCLEXTA as prescribed by your healthcare provider.
See important information about getting started with VENCLEXTA.
VENCLEXTA
is the
PRESCRIBED THERAPY FOR PATIENTS
NEWLY DIAGNOSED WITH AML WHO ARE
INELIGIBLE FOR INTENSIVE CHEMO*
*Based on rolling 3-month IQVIA LAAD claims data for newly diagnosed,
intensive chemo-ineligible AML patients, identified through their use of a
low-intensity regimen <analysis period 7/2021 to ending month 12/2021>.
VENCLEXTA is the
PRESCRIBED THERAPY FOR PATIENTS NEWLY DIAGNOSED WITH AML WHO ARE INELIGIBLE FOR INTENSIVE CHEMO*
*Based on rolling 3-month IQVIA LAAD claims data for newly diagnosed, intensive chemo-ineligible AML patients, identified through their use of a low-intensity regimen <analysis period 7/2021 to ending month 12/2021>.
VENCLEXTA Patient Brochure
For more information about dosing, see the VENCLEXTA Patient Brochure.
Cómo Empezar una Pauta de Tratamiento Basada en VENCLEXTA
Información sobre el tratamiento de la leucemia mieloide aguda (LMA) con VENCLEXTA.
VENCLEXTA oral dosing schedule
Day 1
 |
Take 100 mg of VENCLEXTA and your healthcare provider will start you on azacitidine 75 mg/m2 (IV or SC), or decitabine 20 mg/m2 IV), or cytarabine 20 mg/m2 (SC) as determined by your healthcare provider. |
Day 2
| |
Take 200 mg of VENCLEXTA in combination with azacitidine 75 mg/m2 (IV or SC), or decitabine 20 mg/m2 (IV), or cytarabine 20 mg/m2 (SC) as determined by your healthcare provider. |
Day 3
| |
Take 400 mg of VENCLEXTA in combination with azacitidine 75 mg/m2 (IV or SC), or decitabine 20 mg/m2 (IV), or cytarabine 20 mg/m2 (SC) as determined by your healthcare provider. |
Day 4 and beyond (28-day cycle)
In combination with azacitidine or decitabine:
|
Take 400 mg of VENCLEXTA
in combination with azacitidine 75 mg/m2 (IV or SC) on Days 1–7, or decitabine 20 mg/m2 (IV) on Days 1–5 of each 28-day cycle as determined by your healthcare provider.
OR
In combination with low-dose cytarabine:
|
Take 600 mg of VENCLEXTA
in combination with cytarabine 20 mg/m2 (SC) on Days 1–10 of each
28-day cycle as determined by your healthcare provider.
For illustrative purposes only; pills are not actual size.
Your dosing schedule will be determined by your healthcare provider. Dosing schedules may differ from the examples above if you take medications that could interact with VENCLEXTA.
The recommended dose of VENCLEXTA may be delivered using any of the approved tablet strengths (eg, patients can take 2 x 50 mg tablets or 10 x 10 mg tablets instead of 1 x 100 mg tablet as needed).
Intravenous (IV) means within a vein. In this type of injection, the medication is injected directly into the vein.
Subcutaneous (SC) means under the skin. In this type of injection, the medication is injected into the tissue layer between the skin and the muscle.
VENCLEXTA CALENDAR
Keep track of when you
take
your medication
Actor portrayal.
